» Articles » PMID: 29200475

Pregnancy Outcomes in Maternal Neuropsychiatric Illness and Substance Abuse

Overview
Date 2017 Dec 5
PMID 29200475
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Worldwide the prevalence of neuropsychiatric illness among women of reproductive age is higher than ever before. This study investigates the influences of maternal substance abuse/dependence and neuropsychiatric illness on pregnancy and neonatal outcomes.

Patients And Methods: Using a retrospective study design 185 pregnancies in women with neuropsychiatric illnesses or substance abuse were identified at a single centre over a period of 3.25 years and compared to 4907 pregnancies in healthy women without mental illness. Differences in pre-, peri- and postnatal pregnancy parameters were studied.

Results: Numbers of previous abortions on obstetric history were significantly higher in cases compared to controls, women with depression being especially affected. The number of antenatal visits was also higher among cases, especially in women with depression. The caesarean section rate was significantly higher in cases compared to controls. Children of women with neuropsychiatric illness were born at lower gestational ages than those of healthy control mothers, however there were no significant differences between case and control groups for birth weight, head circumference or Apgar scores. Some isolated differences were found for disease-specific case subgroups compared to controls.

Conclusion: The study shows a relationship between maternal neuropsychiatric illness and pregnancy outcomes independent of medication use. Rates of spontaneous abortion were higher. Children were born earlier, yet the neonatal outcomes birth weight, head circumference and Apgar score were not worse than children of mentally healthy women.

Citing Articles

Risk of depression during pregnancy in usual risk antenatal care.

Silva M, Serrano T, Porcel G, Monteiro B, Clapis M Rev Lat Am Enfermagem. 2023; 31:e3962.

PMID: 37493727 PMC: 10370154. DOI: 10.1590/1518-8345.6463.3962.


Substance use before or during pregnancy and the risk of child mortality, perinatal morbidities and congenital anomalies.

Lee C, Chen V, Lee J, Wu S, Cheng G, Kao T Epidemiol Psychiatr Sci. 2023; 32:e43.

PMID: 37431291 PMC: 10387448. DOI: 10.1017/S2045796023000549.


Risk of depression in pregnancy among pregnant women undergoing high-risk prenatal care.

Ribeiro G, Cieto J, Silva M Rev Esc Enferm USP. 2022; 56:e20210470.

PMID: 35858012 PMC: 10081607. DOI: 10.1590/1980-220X-REEUSP-2021-0470en.


Mindfulness-based Stress Reduction in Pregnancy: an App-Based Programme to Improve the Health of Mothers and Children (MINDFUL/PMI Study).

Lenz B, Eichler A, Schwenke E, Buchholz V, Hartwig C, Moll G Geburtshilfe Frauenheilkd. 2019; 78(12):1283-1291.

PMID: 30686833 PMC: 6337919. DOI: 10.1055/a-0677-2630.

References
1.
Busch M, Maske U, Ryl L, Schlack R, Hapke U . [Prevalence of depressive symptoms and diagnosed depression among adults in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS1)]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013; 56(5-6):733-9. DOI: 10.1007/s00103-013-1688-3. View

2.
Gopman S . Prenatal and postpartum care of women with substance use disorders. Obstet Gynecol Clin North Am. 2014; 41(2):213-28. DOI: 10.1016/j.ogc.2014.02.004. View

3.
Muller V, Makhmadalieva M, Kogan I, Fedorova I, Lesik E, Komarova E . Ectopic pregnancy following in vitro fertilization: meta-analysis and single-center experience during 6 years. Gynecol Endocrinol. 2016; 32(sup2):69-74. DOI: 10.1080/09513590.2016.1232550. View

4.
Cantarutti A, Merlino L, Monzani E, Giaquinto C, Corrao G . Is the Risk of Preterm Birth and Low Birth Weight Affected by the Use of Antidepressant Agents during Pregnancy? A Population-Based Investigation. PLoS One. 2016; 11(12):e0168115. PMC: 5158190. DOI: 10.1371/journal.pone.0168115. View

5.
Murray C, Lopez A . Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997; 349(9064):1498-504. DOI: 10.1016/S0140-6736(96)07492-2. View